Literature DB >> 10606934

Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness.

K G Tournoy1, J C Kips, C Schou, R A Pauwels.   

Abstract

BACKGROUND: House dust mites (HDMs) are the major source of perennial allergens causing human allergic asthma. Animal models mimicking as closely as possible the allergic features observed in human asthma are therefore interesting tools for studying the immunological and pathophysiological mechanisms involved. Especially the role of eosinophils and allergen-specific immunoglobulin (Ig) E in the pathophysiology of airway hyperresponsiveness (AHR) remains a subject of intense debate.
OBJECTIVE: To develop a mouse model of allergic airway inflammation and hyperresponsiveness based on the use of purified house dust mite allergen (Der p 1) as clinical relevant allergen. Furthermore, we studied the effects of low dose allergen exposure on the airway eosinophilia and AHR.
METHODS: On day 0, C57Bl/6 mice were immunized with purified Der p 1 intraperitoneally. From day 14-20, the mice were exposed daily to a 30-min aerosol of different concentrations of house dust mite extract.
RESULTS: Mice, actively immunized with Der p 1 and subsequently exposed to HDM aerosols, developed AHR, eosinophil infiltration of the airways and allergen-specific IgE. Moreover, lowering the concentration of the HDM aerosol also induced AHR and IgE without apparent eosinophil influx into the airways. Der p 1-sensitized mice exposed to PBS produced IgE, but did not show AHR or eosinophil influx.
CONCLUSION: This in vivo model of HDM-induced allergic airway changes suggests that AHR is not related to either eosinophil influx or allergen-specific serum IgE, thereby reducing the importance of these factors as essential elements for allergic AHR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10606934     DOI: 10.1046/j.1365-2222.2000.00772.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  55 in total

1.  Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease.

Authors:  So Ri Kim; Kyung Sun Lee; Seoung Ju Park; Myung Shin Jeon; Yong Chul Lee
Journal:  J Clin Immunol       Date:  2012-02-24       Impact factor: 8.317

2.  Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma.

Authors:  Yong-Geun Kwak; Chang H Song; Ho K Yi; Pyoung H Hwang; Jong-Suk Kim; Kyung S Lee; Yong C Lee
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

3.  Inhibition of pulmonary eosinophilia and airway hyperresponsiveness in allergic mice by rolipram: involvement of endogenously released corticosterone and catecholamines.

Authors:  T T Kung; Y Crawley; B Luo; S Young; W Kreutner; R W Chapman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation.

Authors:  Didier D Cataldo; Kurt G Tournoy; Karim Vermaelen; Carine Munaut; Jean-Michel Foidart; Renaud Louis; Agnès Noël; Romain A Pauwels
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

5.  Fel d 1-airway inflammation prevention and treatment by co-immunization vaccine via induction of CD4+CD25-Foxp3+ Treg cells.

Authors:  Yechun Pei; Shuang Geng; Lin Liu; Fengxiang Yan; Hong Guan; Jian Hou; Yongfu Chen; Bin Wang; Xiaorong An
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

6.  Reproducibility of a novel model of murine asthma-like pulmonary inflammation.

Authors:  L McKinley; J Kim; G L Bolgos; J Siddiqui; D G Remick
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

7.  Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.

Authors:  Mark F Sands; Patricia J Ohtake; Supriya D Mahajan; Shervin S Takyar; Ravikumar Aalinkeel; Yisheng V Fang; Jessica W Blume; Barbara A Mullan; Don E Sykes; Sandra Lachina; Paul R Knight; Stanley A Schwartz
Journal:  Clin Immunol       Date:  2008-10-26       Impact factor: 3.969

8.  Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice.

Authors:  Soo-Jin Park; Dong-Soon Im
Journal:  Br J Pharmacol       Date:  2019-03-14       Impact factor: 8.739

9.  TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice.

Authors:  Laura McKinley; John F Alcorn; Alanna Peterson; Rachel B Dupont; Shernaaz Kapadia; Alison Logar; Adam Henry; Charles G Irvin; Jon D Piganelli; Anuradha Ray; Jay K Kolls
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Airway inflammation and allergen specific IgE production may persist longer than airway hyperresponsiveness in mice.

Authors:  Yoon-Seok Chang; Yoon-Keun Kim; Tae-Bum Kim; Hye-Ryun Kang; Sun-Sin Kim; Joon-Woo Bahn; Kyung-Up Min; You-Young Kim; Sang-Heon Cho
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.